Isomorphic Labs Platform
Harnessing AI to unlock deeper scientific insights for life-changing medicines.
Executive Summary
Isomorphic Labs Platform is an AI-first drug design engine that leverages advanced machine learning, including AlphaFold 3, to revolutionize pharmaceutical research and development. It enables drug discovery experts and scientists to computationally simulate molecular interactions and design novel therapeutics at digital speed. The platform aims to accelerate the identification of promising drug candidates across various disease areas, significantly reducing the time and cost associated with traditional drug development.
Use Cases
- Designing novel small molecules and biologics for therapeutic intervention.
- Predicting protein structures and molecular interactions with high accuracy.
- Accelerating the identification and optimization of drug candidates.
- Exploring previously 'undruggable' targets and new chemical spaces.
- Developing innovative medicines for oncology and immunology.
- Understanding fundamental mechanisms of biology and chemistry.
Features
Visibility
- Near Real-time Predictions: Provides scientists with immediate feedback and predictions to inform their next steps in candidate selection and synthesis.
- In-silico Experiment Visualization: Allows for the visualization of results from massive in-silico experiments and biophysics simulations within the platform.
- Exploration of Chemical Space: Enables researchers to probe new chemical space and explore previously intractable targets with greater pace and precision.
Intelligence
- AI-Driven Molecular Design: Generates new molecule designs for different disease areas and modalities, moving beyond single-target solutions.
- Predictive Modeling of Interactions: Accurately predicts how potential therapeutics interact with their targets in complex biological systems using advanced AI models like AlphaFold 3.
- High-Throughput Hypothesis Assessment: Capable of assessing billions of hypotheses per week, dramatically accelerating the early stages of drug discovery.
- Reduced Experimental Burden: Uses AI to significantly reduce the reliance on time-consuming and costly wet lab experiments.
Support
- Interdisciplinary Team Collaboration: Fosters an environment where machine learning experts, chemists, biologists, and software engineers collaborate closely to develop and apply the technology.
- AlphaFold Server for Research: Offers AlphaFold Server, providing free access to AlphaFold 3's structure prediction capabilities for non-commercial research.
Technical Specifications
- Architecture
- Cloud-native AI-first drug design engine, built on a unified, state-of-the-art architecture.
- Deployment
- Cloud/SaaS
- Authentication
- Not publicly disclosed
- API Available
- Yes
- MCP Server
- No
Infrastructure
- GCP
AI/ML Stack
- Machine Learning
- Generative AI
- Deep Learning
- Reinforcement Learning
Integrations
- Google Cloud
- AlphaFold
Security & Compliance
Encryption: Not publicly disclosed
Pricing
- Model
- Custom enterprise
- Starting Price
- Contact sales
- Target Customer
- Enterprise only
- Contract Type
- Not publicly disclosed
- Free Trial
- No (credit card required)
About Isomorphic Labs
Isomorphic Labs is an AI-first drug design and development company, established as an Alphabet company. It leverages machine learning to reimagine and accelerate the drug discovery process, aiming to model complex biological phenomena to design novel molecules and develop innovative medicines.